Administration of fibrinogen concentrate in exsanguinating trauma patients is associated with improved survival at 6 hours but not at discharge.
Wafaisade, Arasch
Administration of fibrinogen concentrate in exsanguinating trauma patients is associated with improved survival at 6 hours but not at discharge. [electronic resource] - The journal of trauma and acute care surgery Feb 2013 - 387-3; discussion 393-5 p. digital
Publication Type: Clinical Trial; Journal Article
2163-0763
10.1097/TA.0b013e31827e2410 doi
Adult
Exsanguination--drug therapy
Female
Fibrinogen--administration & dosage
Hemostatics--administration & dosage
Hospital Mortality
Humans
Male
Survival Analysis
Time Factors
Wounds and Injuries--complications
Administration of fibrinogen concentrate in exsanguinating trauma patients is associated with improved survival at 6 hours but not at discharge. [electronic resource] - The journal of trauma and acute care surgery Feb 2013 - 387-3; discussion 393-5 p. digital
Publication Type: Clinical Trial; Journal Article
2163-0763
10.1097/TA.0b013e31827e2410 doi
Adult
Exsanguination--drug therapy
Female
Fibrinogen--administration & dosage
Hemostatics--administration & dosage
Hospital Mortality
Humans
Male
Survival Analysis
Time Factors
Wounds and Injuries--complications